The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2026" has been added to ResearchAndMarkets.com's offering. Global Induced Pluripotent Stem Cell ...
iPSC-derived cell models are a widely used tool that enables scientists to generate various cell types, organoids, and tissues. They are also instrumental in creating disease-specific phenotypes using ...
In a recent study published in iScience, researchers have optimized the Tet-On system to improve the efficiency of generating skeletal muscle cells and other differentiated cell types from iPSCs for ...
Induced pluripotent stem cells (iPSCs) are characterized by the ability to self-renew and retain their pluripotency just like embryonic stem cells. As a result, they have the ability to be ...
Human induced pluripotent stem cell (iPSC) technology has enabled the generation of virtually any human cell type from somatic cells obtained from healthy or disease donors. This powerful platform has ...
The spectrum of metabolic dysfunction-associated steatotic liver disease (MASLD) ranges from simple lipid accumulation in the human liver, to steatohepatitis with inflammation, fibrosis, cirrhosis, ...
On March 18, 2026, Frost & Sullivan and Forbes China Group jointly hosted the 2026 FORBES CHINA PIONEER INNOVATORS IN INDUSTRY DEVELOPMENT SELECTION GALA BANQUET at the Bulgari Hotel in Shanghai. The ...
UniXell Biotechnology Co., Ltd. ('UniXell') has secured Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for UX-DA003, its allogeneic induced pluripotent stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results